Acute severe pulmonary hypertension during weaning from cardiopulmonary bypass for aortic valve replacement surgery: A case report

Abstract

Pulmonary arterial pressure (PAH) usually increases after cardiopulmonary bypass (CPB), but this normally does not affect weaning off CPB. Here we report a case of severe PAH in a patient with normal left atrial pressure. Prolonging CPB by 45 min did not lead to lower PAH. Given that lung injury can stimulate secretion of vasoconstrictors that trigger PAH, we decided to gradually increase blood flow into the lungs in an effort to restore the balance between pulmonary vasoconstrictors and vasodilators. Pulmonary artery pressure gradually decreased, allowing the patient to be weaned off CPB, after which she recovered uneventfully. Our experience suggests an approach for managing acute, severe PAH after CPB without the need for mechanical circulatory support.

Keywords

pulmonary arterial hypertension cardiopulmonary bypass lung ischemia right ventricular dysfunction pulmonary blood flow

Get full access to this article

View all access options for this article.

References

Fattouch

Sbraga

Sampognaro

, et al. Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study. J Cardiovasc Med (Hagerstown) 2006; 7: 119–123.

Brida

Gatzoulis

. Pulmonary arterial hypertension in adult congenital heart disease. Heart 2018; 104: 1568–1574.

Denault

Deschamps

Tardif

, et al. Pulmonary hypertension in cardiac surgery. Curr Cardiol Rev 2010; 6: 1–14.

Price

Martinez

Brame

, et al. Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement. Br J Anaesth 2021; 126: 774–790.

Chester

Yacoub

. The role of endothelin-1 in pulmonary arterial hypertension. Glob Cardiol Sci Pract 2014; 2014: 62–78.

Hemnes

Brittain

. Autonomic nervous system in pulmonary arterial hypertension: time to rest and digest. Circulation 2018; 137: 925–927.

Subramaniam

Yared

. Management of pulmonary hypertension in the operating room. Semin Cardiothorac Vasc Anesth 2007; 11: 119–136.

den Hengst

Gielis

Lin

, et al. Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol 2010; 299: H1283–H1299.

Michelakis

Tymchak

Lien

, et al. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation 2002; 105: 2398–2403.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB